| Ms Michele L Polfuss, NP | |
|
Chw-fox Valley Theda Clark Med Ctr, 130 Second Street, Neenah, WI 54956 | |
| (920) 969-7900 | |
| Not Available |
| Full Name | Ms Michele L Polfuss |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics |
| Location | Chw-fox Valley Theda Clark Med Ctr, Neenah, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164476156 | NPI | - | NPPES |
| 43972900 | Medicaid | WI | |
| 007000261Y | Other | HUMANA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0200X | Nurse Practitioner - Pediatrics | 1628 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Michele L Polfuss, NP 130 2nd St, Chw-fox Valley Theda Clark Med Ctr, Neenah, WI 54956-2883 Ph: () - | Ms Michele L Polfuss, NP Chw-fox Valley Theda Clark Med Ctr, 130 Second Street, Neenah, WI 54956 Ph: (920) 969-7900 |
News Archive
A nationwide study of children who have witnessed domestic violence found that parents or caregivers were physically injured in more than a third of the cases, yet only a small fraction of offenders went to jail and just one in four incidents resulted in police reports, according to new research published by the American Psychological Association.
The ALS research team at Umea University in Sweden, working with Dutch and Belgian colleagues, has found new connections between mutations in gene DPP6 and contracting the non-hereditary form of ALS. The findings are being published december 16 in Nature Genetics on the Web.
Amgen Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Prolia™ (denosumab) for the treatment of postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture; or patients who have failed or are intolerant to other available osteoporosis therapy. Prolia, the first and only FDA-approved RANK Ligand inhibitor, is an every six month 60 mg subcutaneous injection administered by a health care professional.
Chronic pain affects about 76 million people in the U.S. and carries an economic burden of nearly $100 billion annually. The most frequently used medications, narcotic and non-narcotic analgesic drugs (e.g., morphine, ibuprofen, etc.), do not provide complete or sustained relief of chronic pain. Scientists are currently seeking alternative solutions for chronic pain management.
Screening practices for multidrug-resistant organisms (MDROs) in intensive care units (ICUs) vary widely from hospital to hospital, according to a new study published in the October issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 9 days ago
Mrs. Amanda Kay Douma, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 333 N Green Bay Rd Ste B, Neenah, WI 54956 Phone: 920-454-7130 | |
Lori A. Franck, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Theda Clark Medical Plz Ste 400, Neenah, WI 54956 Phone: 920-725-4527 | |
Mrs. Bonnie B Hoersch, APNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2738 Fax: 920-729-3023 | |
Pamela Macwilliams, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 2nd St Ste 197, Neenah, WI 54956 Phone: 920-729-2030 | |
Ellen Beltz, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2738 | |
Marie K Dziewit, APNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 Theda Clark Medical Plz Ste 400, Neenah, WI 54956 Phone: 920-725-4527 Fax: 920-729-2378 | |
Brittany R Burg, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 130 2nd St, Neenah, WI 54956 Phone: 920-729-2030 Fax: 920-729-9384 |